Masana kimiyya a Jami'ar Jihar Michigan suna tsara wani nau'i mai kama da kwayar cuta mai suna Qβ, wanda zai haifar da amsawar rigakafin ciwon daji a cikin jiki kuma ana iya amfani dashi a matsayin sabon maganin maganin ciwon daji. Aikin dalar Amurka miliyan 2.4 da Cibiyar Kula da Ciwon daji ta kasa ta bayar zai tallafa wa samar da alluran rigakafi don kare dabbobi daga kwayoyin cutar kansa da ba za a iya warkewa a halin yanzu ba, kuma maiyuwa ne rigakafin cutar kansar kwatsam a cikin mutane.
Theungiyar za ta haɗu da ƙwayoyin Qβ tare da antigens (TACAs) masu alaƙa da ƙari (kuma TACAs), kuma sun yi imanin cewa waɗannan antigens ɗin za su samar da cikakken ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta, rage haɓakar tumo da hana ci gaban tumo. Bugu da kari, masu binciken za su yi amfani da tsarin kristal na Qβ don samar da maye gurbi wanda ke rage kwayoyi masu guba da inganta kwayayen da ake so, wanda kuma zai iya kashe kwayoyin cutar kansa. Wannan ita ce irin wannan gwaji ta farko ta amfani da samfurin rigakafin TACA.
This vaccine will be used first to treat canine cancer and will focus on osteosarcoma, which is a refractory dog and human bone tumo.
Vaccines can reduce tumor growth and protect patients from tumor progression and further progress. If we can further understand the relationship between the structural characteristics of Qβ-TACA and anti-tumor immunity, it can have a great effect on the design of maganin ciwon daji. This research also strengthens the important role of veterinary medicine in cancer research.
Yuzbasiyan-Gurkan ya ce: “Ciwon kansa ba da daɗewa ba a cikin karnuka da kuliyoyi yana ba da gwaji na gaske game da rigakafin cutar kansa. Wannan misali daya ne kawai daga cikin hanyoyin da likitocin dabbobi da na likitanci za su iya amfani da juna. ”
